Hi,

International doctors get virtually no training on the endocannabinoid system, even though it affects pain, mood, and sleep, among other things. Public cannabis companies lost $2B last year while making $8.5B in sales. Trump’s DEA pick says he will make investigating cannabis rescheduling a top priority, but refused to say if he wanted cannabis to be rescheduled. We are going to have to wait to find out what that means. ;)

Feel free to subscribe to our Cannabis or CBD News Roundups.

Thanks and have an impressive week!
Jessica

05/01/25
LEEF Brands Inc. (CSE: LEEF) (OTCQB: LEEEF) reports first quarter 2025 and full-year 2024 financial results

04/30/25
Christina Lake Cannabis Corp. (CSE: CLC) (OTCQB: CLCFF) closes first tranche of non-brokered private placement
Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) announces upsize of private placement offering under the listed issuer financing exemption
The Scotts Miracle-Gro Company (NYSE: SMG) reports second quarter results
Chicago Atlantic BDC, Inc. (NASDAQ: LIEN) announces first quarter 2025 financial results conference call

04/29/25
Vireo Growth Inc. (CSE: VREO; OTCQX: VREOF) to release first quarter 2025 results on may 9, 2025